Related Experiment Video
Updated: Mar 25, 2026
09:13
Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
Published on: January 5, 2024
2.1K
Pentoxifylline affects idarubicin binding to DNA.
Grzegorz Gołuński1, Agnieszka Borowik1, Andrea Lipińska2
1Laboratory of Biophysics, Intercollegiate Faculty of Biotechnology UG-MUG, Abrahama 58, 80-307 Gdańsk, Poland.
Bioorganic Chemistry
|February 28, 2016
Summary
This study investigates how pentoxifylline affects the anticancer drug idarubicin
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Idarubicin, a doxorubicin derivative, is a widely used anticancer drug.
- Its biophysical properties and interactions with other compounds are not fully understood.
- Potential interactions between idarubicin and pentoxifylline could impact drug efficacy.
Purpose of the Study:
- To characterize the biophysical properties of idarubicin.
- To evaluate the influence of pentoxifylline on idarubicin's interaction with DNA.
- To explore potential direct interactions between idarubicin and pentoxifylline.
Main Methods:
- Spectrophotometric methods with mathematical modeling.
- Flow cytometry.
- Ames test for mutagenicity.
Main Results:
- Pentoxifylline alters idarubicin's DNA binding.
- Results align with previous studies on aromatic ligand interactions.
- Direct idarubicin-pentoxifylline interactions may affect anticancer activity.
Conclusions:
- Pentoxifylline influences idarubicin's DNA binding properties.
- Further research is needed to understand the clinical implications of these interactions.
- Direct drug-drug interactions could modulate idarubicin's therapeutic effect.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
66
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
66
01:09Hepatic Drug Clearance: Effect of Protein Binding
666
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
666
01:16Drug toxicity: Idiosyncratic Reactions
162
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
162
01:28Inhibitors of Bacterial DNA Synthesis
18
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
18
01:21Drug Distribution: Tissue Binding
4.4K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
4.4K
01:18Effects of EDTA on End-Point Detection Methods
754
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
754